SORRY. You cannot make these kinds of claims based upon 401 individuals. Rerun the study with 100 times this number of kids and get back to me.
—
400 test subjects. The exact same number used to ok the booster vaxx shot.
https://clinicaltrials.gov/ct2/show/NCT05057169
https://clinicaltrials.gov/ct2/show/NCT05057169
Compliments. A good catch (if that's the correct expression).
The “gold standard” which the pharmaceuticals’ sales has been touting often involves very small subjects.
Here's another:
“A total of 1062 patients underwent randomization (with 541 assigned to remdesivir and 521 to placebo).”
In “Remdesivir for the Treatment of Covid-19 — Final Report”
https://www.nejm.org/doi/full/10.1056/NEJMoa2007764
Again compliments on presenting sourced data to counter unsourced assertions.
Bravo!